Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with ...
Fatigue, cognitive changes and sleep disturbances were as important to patients with early Parkinson’s disease as symptoms ...
Oryon Cell Therapies emerged from stealth on Monday with $21 million in new funding and early clinical data showing signs ...
Regenxbio said on Wednesday that interim data from a early-to-mid stage study of its experimental gene therapy in patients ...
Parkinson’s weight loss is increasingly recognised as a key factor in disease progression, linked to frailty, cognitive decline and reduced quality of life.
Hyundai Motor Group builds on the NVIDIA DRIVE Hyperion platform to accelerate development of data-driven autonomous driving ...
Oryon Cell Therapies (“Oryon”), a clinical-stage biotechnology company focused on developing autologous neuron replacement ...
Panasonic Automotive Systems Co., Ltd. (Headquarters: Yokohama, Kanagawa, Japan; President: Masashi Nagayasu) today announced ...
Correspondence to Dr Iain Mayank Dutia, The University of Queensland School of Human Movement and Nutrition Sciences, Saint Lucia, QLD 4072, Australia; i.dutia{at}uq.edu.au Objective This study aims ...
A new study reveals that astrocytes-star-shaped support cells traditionally viewed as passive partners of neurons-play a ...
A new study reveals that astrocytes—star-shaped support cells traditionally viewed as passive partners of neurons—play a ...
Mohr Marketing, LLC, the nation’s leading innovator in compliant legal intake and marketing infrastructure, today announced the national expansion of its Police Report Program—a groundbreaking, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results